CClinicalTrials.gg
CompletedNCT03017079Updated Nov 2, 2021Results posted

A More Physiological Feeding Process in ICU:the Intermittent Infusion With Semi-solidification of Nutrients

An interventional study of semi-solid agent with standard enteral feeding and standard enteral feeding in Nutrition, Enteral, sponsored by Second Affiliated Hospital, School of Medicine, Zhejiang University. Completed at 1 site in China. Open to participants aged 14 Years to 90 Years. Per ClinicalTrials.gov, last updated 2021-11-02.

Sponsored by Second Affiliated Hospital, School of Medicine, Zhejiang University · Not applicable, Interventional, and Prevention

From the registry’s dates

  • Registered 7 months after the study started (first participant enrolled Jun 2016, registered Jan 2017).
Phase
Not applicable
Study type
Interventional
Enrollment
40
Allocation
Randomized
Ages
14 Years to 90 Years
Sex
All
01

Study summary

Malnutrition and underfeeding are major challenges in caring for critically ill patients. Continuous feeding were thought to be better tolerated by patients with the limited absorptive gut surface area or gastrointestinal dysfunction, but associated with more tube clogging and required the patient to be attached to an infusion pump for significant periods of time. Intermittent infusion resembled more physiological feeding process, which allowed greater patient mobility and might reach goal enteral calories earlier, and the latter were considered to effectively decrease the length of stay (LOS)-in-hospital and mortality. However, it also had some previous study found that intermittent infusion had more complications, such as diarrhea, regurgitation than continuous. Some study found that it was an efficient way to prevent aspiration and reflux by increasing the enteral nutrient solution viscosity and improve bolus intermittent feeding intolerance. The primary goal of this was to study whether receiving semi-solidification of nutrients could increase the percent prescribed calories received by improving the feeding intolerance, and secondary goal was to observing the effect of semi-solid nutrient to the LOS of ICU and in-hospital, lung infection, 30-days mortality and the glycemic variability (GV).

Read the detailed description

Enteral nutrition (EN) therapy is an essential part in critically ill patients,and can be administered on a continuous or intermittent, but there were no consensus on which should be adopted. Continuous feeding were thought to be better tolerated by patients with the limited absorptive gut surface area or gastrointestinal dysfunction, but associated with more tube clogging and required the patient to be attached to an infusion pump for significant periods of time. Intermittent infusion resembled more physiological feeding process, which allowed greater patient mobility and might reach goal enteral calories earlier, and the latter were considered to effectively decrease the LOS-in-hospital and mortality. However, it also had some previous study found that intermittent infusion had more complications, such as diarrhea, regurgitation than continuous.

Recently, some study found that it was an efficient way to prevent aspiration and reflux by increasing the enteral nutrient solution viscosity and improve bolus intermittent feeding intolerance. In dementia or Parkinson's patients, one study showed that high-viscosity liquid meal could decrease the incidence of aspiration, compared with the thin liquid, but the study about the viscosity of nutrition was little and the sample size was small.

In this study, the primary goal of this was to study whether receiving semi-solidification of nutrients could increase the percent prescribed calories received by improving the feeding intolerance, and secondary goal was to observing the effect of semi-solid nutrient to the LOS of ICU and in-hospital, lung infection, 30-days mortality and the glycemic variability (GV).

02

Conditions studied

  • Nutrition, Enteral

Keywords

  • Semi-solidification
  • caloric debt
  • enteral nutrition
  • critical illness
03

In context

Lead sponsor

Second Affiliated Hospital, School of Medicine, Zhejiang University is the lead sponsor of 1,058 studies on the registry; 511 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
14 Years to 90 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

(1)14 years and older, who received EN for more than 72 hours, were eligible for inclusion (2) all patients started on EN by nasogastric tube

Exclusion criteria

Exclusion Criteria:

  1. received EN \<72 hours
  2. received EN prior to ICU admission
  3. had acute pulmonary infection
  4. had history of Gastrointestinal surgery
  5. had contraindications of EN, such as intestinal obstruction (mechanical or paralytic ileus).
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
40 participants (actual)

Study arms

  • Experimental
    semi-solidification with nutrient

    semi-solidification with nutrient:after infusion of semi-solid agent, enteral nutrition is applied less than 60 mins. Intervention: Other: bolus Intermittent enteral feeding

    Dietary Supplement: semi-solid agent with standard enteral feeding

  • Placebo comparator
    Standard enteral nutrition

    After infusion of Sterile Water for Injection,bolus Intermittent enteral feeding via the nasogastric tube is applied less than 60 mins. Intervention: Other: Standard enteral feeding

    Other: standard enteral feeding

Interventions

  • Dietary supplementsemi-solid agent with standard enteral feeding

    after infusion of semi-solid agent, Intermittent enteral feeding is applied less than 60 minutes

    Also known as: semi-solidification of nutrient

  • Otherstandard enteral feeding

    Intermittent enteral feeding is applied less than 60 minutes

    Also known as: standard enteral nutrition

06

What researchers measure

Primary outcomes

  1. the Ratio of the Enteral Nutrition

    the ratio of the enteral nutrition=administered volume of enteral nutrition / prescribed volume of nutrition X 100%; This ratio fluctuates between 0 and 100%, and the higher the ratio, the higher the execution rate

    Time frame: 3 days after receiving enteral nutrition

Secondary outcomes

  1. the Patient of Feeding Intolerance(FI)

    the definition of FI was included one of the conditions:diarrhea, vomiting, regurgitation, obvious bowel distension and GRV\>200mL. Due to the small sample size, only the number of patients who occurred was recorded.

    Time frame: 3 days

  2. the Patients With Lung Infection

    patient contain the following three conditions: 1.Sputum volume increased or Sputum properties change;2.CT Scan-Chest suggest that there was lung infection; 3.CRP and / or PCT increased

    Time frame: 7 days

  3. 30-days Mortality

    dead within 30 days in ICU

    Time frame: 30 days

  4. the Glycemic Variability(GV)

    Divided into three grades:I:GV less than 4mmol/24h; II 4-6mmol/24h;III more than 6mmol/24h

    Time frame: 3 days

  5. Length of Hospital Stay (LOS)

    every participators stayed in hospital

    Time frame: 30 days

07

Results

Posted Nov 2, 2021

Participant flow

Participant flow — Overall Study
MilestoneSemi-solidification With NutrientStandard Enteral Nutrition
Started2020
Completed1414
Not completed66
Withdrew: Physician decision11
Withdrew: Death32
Withdrew: Lack of efficacy22
Withdrew: Protocol violation01

Outcome measures

Primarythe Ratio of the Enteral Nutrition

the ratio of the enteral nutrition=administered volume of enteral nutrition / prescribed volume of nutrition X 100%; This ratio fluctuates between 0 and 100%, and the higher the ratio, the higher the execution rate

Time frame:
3 days after receiving enteral nutrition
Reported as:
Mean · ratio
the Ratio of the Enteral Nutrition
ratioIntermittent Feeding With Semi-solid NutrientsStandard Enteral Feeding
the Ratio of the Enteral Nutrition0.98 ± 0.0670.73 ± 0.15
Secondarythe Patient of Feeding Intolerance(FI)

the definition of FI was included one of the conditions:diarrhea, vomiting, regurgitation, obvious bowel distension and GRV\>200mL. Due to the small sample size, only the number of patients who occurred was recorded.

Time frame:
3 days
Reported as:
Number · participants
the Patient of Feeding Intolerance(FI)
participantsIntermittent FeedingIntermittent Feeding With Semi-solid Nutrients
the Patient of Feeding Intolerance(FI)82
Statistical analysis
  • Intermittent Feeding · t-test, 2 sided · p = 0.05
Secondarythe Patients With Lung Infection

patient contain the following three conditions: 1.Sputum volume increased or Sputum properties change;2.CT Scan-Chest suggest that there was lung infection; 3.CRP and / or PCT increased

Time frame:
7 days
Reported as:
Number · participants
the Patients With Lung Infection
participantsIntermittent FeedingIntermittent Feeding With Semi-solid Nutrients
the Patients With Lung Infection87
Statistical analysis
  • Intermittent Feeding vs Intermittent Feeding With Semi-solid Nutrients · t-test, 2 sided · p = 0.05 · Odds ratio (or): 0.05
Secondary30-days Mortality

dead within 30 days in ICU

Time frame:
30 days
Reported as:
Number · participants
30-days Mortality
participantsIntermittent Feeding With Semi-solid NutrientsIntermittent Feeding
The number of deaths within 30 days after ICU32
The number of live after 30 days in ICU1112
Statistical analysis
  • Intermittent Feeding With Semi-solid Nutrients · Chi-squared, Corrected · p = 0.05
Secondarythe Glycemic Variability(GV)

Divided into three grades:I:GV less than 4mmol/24h; II 4-6mmol/24h;III more than 6mmol/24h

Time frame:
3 days
Reported as:
Mean · mmol/l
the Glycemic Variability(GV)
mmol/lIntermittent Feeding With Semi-solid NutrientsIntermittent Feeding
1d-0h7.514 ± 2.23098.457 ± 2.9456
1d-4h8.336 ± 2.16539.700 ± 3.1001
1d-8h9.229 ± 3.25879.664 ± 3.1023
1d-12h9.342857 ± 3.13533578.985714 ± 3.2846630
1d-16h8.635714 ± 2.40691548.992857 ± 3.1086639
1d-20h8.064286 ± 1.97274008.721429 ± 2.5137097
2d-0h8.436 ± 2.20168.686 ± 2.9493
2d-4h8.857 ± 2.56879.450 ± 3.1889
2d-8h10.471 ± 3.06989.064 ± 2.8527
2d-12h9.543 ± 3.52139.514 ± 3.6367
2d-16h9.343 ± 3.44698.821 ± 3.6413
2d-20h8.807 ± 3.41307.807 ± 2.8073
3d-0h8.135714 ± 2.55481668.250000 ± 4.3164711
3d-4h8.579 ± 2.82829.486 ± 3.7223
3d-8h9.121 ± 2.80118.879 ± 3.0238
3d-12h8.721 ± 2.80729.429 ± 3.0648
3d-16h9.328571 ± 3.22572088.935714 ± 2.2210902
3d-20h8.250000 ± 2.32998847.957143 ± 2.0129253
SecondaryLength of Hospital Stay (LOS)

every participators stayed in hospital

Time frame:
30 days
Reported as:
Mean · days
Length of Hospital Stay (LOS)
daysIntermittent Feeding With Semi-solid NutrientsIntermittent Feeding
Length of Hospital Stay (LOS)20.07 ± 25.7114.36 ± 7.59
Statistical analysis
  • Intermittent Feeding With Semi-solid Nutrients vs Intermittent Feeding · Chi-squared, Corrected · p = <0.05

Adverse events

Collected over Total follow-up 1 month. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Standard Enteral Nutrition2/14 (14.3%)0/14 (0%)0/14 (0%)
Semi-solidification With Nutrient3/14 (21.4%)0/14 (0%)0/14 (0%)

Baseline characteristics

Age, Continuous
Age, Continuous(years)Semi-solidification With NutrientStandard Enteral NutritionTotal
Mean54.93 ± 20.9652.14 ± 13.7753.54 ± 17.45
Sex: Female, Male
Sex: Female, Male(Participants)Semi-solidification With NutrientStandard Enteral NutritionTotal
Female5510
Male9918
Ethnicity (NIH/OMB)
Ethnicity (NIH/OMB)(Participants)Semi-solidification With NutrientStandard Enteral NutritionTotal
Hispanic or Latino000
Not Hispanic or Latino000
Unknown or Not Reported141428
Race (NIH/OMB)
Race (NIH/OMB)(Participants)Semi-solidification With NutrientStandard Enteral NutritionTotal
American Indian or Alaska Native000
Asian141428
Native Hawaiian or Other Pacific Islander000
Black or African American000
White000
More than one race000
Unknown or Not Reported000
Region of Enrollment
Region of Enrollment(participants)Semi-solidification With NutrientStandard Enteral NutritionTotal
China141428
NRS 2002
NRS 2002(units on a scale)Semi-solidification With NutrientStandard Enteral NutritionTotal
Mean3.14 ± 0.772.86 ± 0.953 ± 0.86
08

Study locations

1 site
  • Second affiliated hospital, Zhejiang university school of medicine
    Hangzhou, Zhejiang 310052, China
09

References and documents

Publications

  • Peev MP, Yeh DD, Quraishi SA, Osler P, Chang Y, Gillis E, Albano CE, Darak S, Velmahos GC. Causes and consequences of interrupted enteral nutrition: a prospective observational study in critically ill surgical patients. JPEN J Parenter Enteral Nutr. 2015 Jan;39(1):21-7. doi: 10.1177/0148607114526887. Epub 2014 Apr 7. PubMed 24714361 ↗
  • Evans DC, Forbes R, Jones C, Cotterman R, Njoku C, Thongrong C, Tulman D, Bergese SD, Thomas S, Papadimos TJ, Stawicki SP. Continuous versus bolus tube feeds: Does the modality affect glycemic variability, tube feeding volume, caloric intake, or insulin utilization? Int J Crit Illn Inj Sci. 2016 Jan-Mar;6(1):9-15. doi: 10.4103/2229-5151.177357. PubMed 27051616 ↗
  • MacLeod JB, Lefton J, Houghton D, Roland C, Doherty J, Cohn SM, Barquist ES. Prospective randomized control trial of intermittent versus continuous gastric feeds for critically ill trauma patients. J Trauma. 2007 Jul;63(1):57-61. doi: 10.1097/01.ta.0000249294.58703.11. PubMed 17622869 ↗
  • Taylor BE, McClave SA, Martindale RG, Warren MM, Johnson DR, Braunschweig C, McCarthy MS, Davanos E, Rice TW, Cresci GA, Gervasio JM, Sacks GS, Roberts PR, Compher C; Society of Critical Care Medicine; American Society of Parenteral and Enteral Nutrition. Guidelines for the Provision and Assessment of Nutrition Support Therapy in the Adult Critically Ill Patient: Society of Critical Care Medicine (SCCM) and American Society for Parenteral and Enteral Nutrition (A.S.P.E.N.). Crit Care Med. 2016 Feb;44(2):390-438. doi: 10.1097/CCM.0000000000001525. No abstract available. PubMed 26771786 ↗
  • Logemann JA, Gensler G, Robbins J, Lindblad AS, Brandt D, Hind JA, Kosek S, Dikeman K, Kazandjian M, Gramigna GD, Lundy D, McGarvey-Toler S, Miller Gardner PJ. A randomized study of three interventions for aspiration of thin liquids in patients with dementia or Parkinson's disease. J Speech Lang Hear Res. 2008 Feb;51(1):173-83. doi: 10.1044/1092-4388(2008/013). PubMed 18230864 ↗
  • Bardhan KD, Strugala V, Dettmar PW. Reflux revisited: advancing the role of pepsin. Int J Otolaryngol. 2012;2012:646901. doi: 10.1155/2012/646901. Epub 2011 Nov 10. PubMed 22242022 ↗
  • Hayat JO, Gabieta-Somnez S, Yazaki E, Kang JY, Woodcock A, Dettmar P, Mabary J, Knowles CH, Sifrim D. Pepsin in saliva for the diagnosis of gastro-oesophageal reflux disease. Gut. 2015 Mar;64(3):373-80. doi: 10.1136/gutjnl-2014-307049. Epub 2014 May 7. PubMed 24812000 ↗
  • Lu K, Zeng F, Li Y, Chen C, Huang M. A more physiological feeding process in ICU: Intermittent infusion with semi-solid nutrients (CONSORT-compliant). Medicine (Baltimore). 2018 Sep;97(36):e12173. doi: 10.1097/MD.0000000000012173. PubMed 30200118 ↗

Study documents

  • Study protocol · Nov 24, 2016
  • Statistical analysis plan · Nov 24, 2016
  • Informed consent form · Nov 24, 2016

Documents are hosted by the registry — open the source record to download them.

Individual participant data

Plan to share: No

10

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Nov 2, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT03017079
Lead sponsor
Second Affiliated Hospital, School of Medicine, Zhejiang University
Responsible party
Man Huang, Ph.D (Clinical Professor, Second Affiliated Hospital, School of Medicine, Zhejiang University) — Principal investigator
First posted
Jan 11, 2017
Start date
Jun 1, 2016
Primary completion
Mar 1, 2017
Completion
Mar 1, 2017
Results posted
Nov 2, 2021
Last update
Nov 2, 2021

Study contacts

man huang, phD
principal investigator · Second affiliated hospital, Zhejiang university school of medicine

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion